9/8/2022 4:38:45 PM
Geron Appoints John McDonald To Board Of Directors
8/11/2022 4:08:47 PM
Geron Corp. Q2 Loss/share $0.07 Vs. Loss $0.09 Year Ago
6/15/2022 4:22:33 PM
Geron Corp. Appoints Faye Feller As Chief Medical Officer
5/9/2022 4:14:12 PM
Geron Q1 Loss/share $0.09, Same As Last Year
3/10/2022 4:11:04 PM
Geron Corp. Q4 Loss/share $0.10 Vs. Loss $0.07 Year Ago
12/2/2021 7:33:26 AM
Geron Appoints Edward Koval As EVP And Chief Business
Officer
10/18/2021 7:36:20 AM
Geron Completes Patient Enrollment In IMerge Phase 3 Trial In Lower Risk Myelodysplastic Syndromes